Your browser doesn't support javascript.
loading
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Ott, Patrick A; Pavlick, Anna C; Johnson, Douglas B; Hart, Lowell L; Infante, Jeffrey R; Luke, Jason J; Lutzky, Jose; Rothschild, Neal E; Spitler, Lynn E; Cowey, C Lance; Alizadeh, Aaron R; Salama, April K; He, Yi; Hawthorne, Thomas R; Bagley, Rebecca G; Zhang, Joshua; Turner, Christopher D; Hamid, Omid.
Afiliação
  • Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Pavlick AC; Department of Medical Oncology, New York University School of Medicine, New York, New York.
  • Johnson DB; Department of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Hart LL; Florida Cancer Specialists and Research Institute, Fort Myers, Florida.
  • Infante JR; Tennessee Oncology, PLLC, Nashville, Tennessee.
  • Luke JJ; Department of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois.
  • Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida.
  • Rothschild NE; Florida Cancer Specialists, West Palm Beach, Florida.
  • Spitler LE; St. Mary's Medical Center, San Francisco, California.
  • Cowey CL; Northern California Melanoma Center, Baylor University Medical Center, Dallas, Texas.
  • Alizadeh AR; Northside Hospital Cancer Institute, Decatur, Georgia.
  • Salama AK; Department of Medical Oncology, Duke University, Durham, North Carolina.
  • He Y; Celldex Therapeutics, Inc, Hampton, New Jersey.
  • Hawthorne TR; Celldex Therapeutics, Inc, Hampton, New Jersey.
  • Bagley RG; Celldex Therapeutics, Inc, Hampton, New Jersey.
  • Zhang J; Celldex Therapeutics, Inc, Hampton, New Jersey.
  • Turner CD; Celldex Therapeutics, Inc, Hampton, New Jersey.
  • Hamid O; The Angeles Clinic and Research Institute, Los Angeles, California.
Cancer ; 125(7): 1113-1123, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30690710
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Imunoconjugados / Antineoplásicos Imunológicos / Melanoma / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Imunoconjugados / Antineoplásicos Imunológicos / Melanoma / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article